Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

about

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

Item

http://www.wikidata.org/entity/Q47695767

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

@en

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

@nl

type

Item

label

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

@en

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

@nl

prefLabel

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

@en

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

@nl

P1476

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.

@en

P2093

David Roth

http://www.w3.org/2001/XMLSchema#string

Marco Ladino

http://www.w3.org/2001/XMLSchema#string

P2860

Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.

Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?

Hepatitis C Virus Infection in Chronic Kidney Disease.

Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

P2888

nrneph.2017.161

P304

6-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2017.161

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29176656

http://www.w3.org/2001/XMLSchema#string